Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8 USD | 0.00% | 0.00% | +433.33% |
Evolution of the average Target Price on Silence Therapeutics plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Silence Therapeutics plc
Chardan Research | |
Morgan Stanley | |
BMO Capital | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- SLN Stock
- SLNCF Stock
- Consensus Silence Therapeutics plc